Proceedings of the 39th Annual ASTRO Meeting
279
2077 OPTIMUM
FRACTIONATION
IRRADIATION
Y. Akagi,’
FOR HIGH
OF SUPERFICIAL
Y. Hirokawa,r
DOSE
of Radiology,
Hlroshhna
Unversity
Qepartment
of Radiology,
Hiroshima
City Hospital,
Materials
and
mediastin~ Hiroshhna and spinal
School
2A.Ito,tK.
Fujita,rK.
Matsuura,*M.Kenjo,rH.
of Medicine,
Hiroshima,
Japan
Hiroshima,
FOLLOWING
EXTERNAL
Khiu,rK.Itor
Japan
To establish an optimum fractionation data of patients treated with different HDR Methods: The study population consists
from retrcspectivc
BRACHYTHERAPY
CANCER
T. Kawakami,
M. Kagemoto,z
IDepartment
Objective/Purpose:
RATE INTRALUMINAL
ESOPHAGEAL
for high dose rate (HDR) intraluminal schedules following external Irradiation. of consecutive superficial esophageal
brachytherapy
for superficial
cancer
who
patients
esophageal
received
cancer
external
beam
Irradiation plus tit11 dose intraluminal brachytherapy from May 1992 to November 1995 in Hiroshima University Medical Center and City Hospital. lbere were 35 eligible cases. All patients were treated with external beam irradiation to doses ranging from 50 to 61 Gy, cord was spared after 44 to 45 Gy. HDR intraluminal brachytherapy boost with double balloon applicator was used by [r-192(10 Ci to
4.3 Ci) remote afterloading systemsone group of 10 patients was treated with 2 or 3 lntrahrminal boosts given a week apart with a dose of 4 or 5 Gy at a distance of 5 mm from the applicator surface, and another group of 25 patients was treated 4 or 5 intraluminal boosts given in a week with a dose of 2 or 2.5 Gy. The linear quadratic (IQ) formula was used to calculate the biologically effective dose (BED) to tumor( Gyro) and esophageal mucosa(
Gys).
Kaplan-Meyer
method
was used to calculated
was used to study for significance. Results: Six (17%) of the 35 patients
for local control
rates and late complication
occurrence
rates and generalized
Wilcoxon
method
recurred
and 7 (20%)
correlate with local control and late complications. tumor control may be compromised with a tumor 2.0 Gy at a distance below 142 Gys and
had late complication
(esophageal
ulcer
> Grade
l).The
M
formula
appears
A BED above 142 Gys was associated with Grade 2+3(RTOG) esophageal ulcers. BED above 96 Gyto. A BED analysis showed that the fraction size should be decreased
of 5 mm from the applicator surface a BED above 96 Gyro give approval.
and the fraction
number
should
be increased
to 4 or 5 times, respectively
, to let a BED
A larger reduction of brachytherapy dose is necessary for reduction of late complications. Our most recently developed esophageal cancer patients is 5 time applications on a week with 2 Gy at a distance of 5 mm from the applicator surface
Conclusion:
superficial external
irradiation
schedule following
for an
of 60 Gy
2078 RADIOTHERAPY
FOR SUPERFICIAL
Yoshikazu
Kagami.
Hiroshi
Tokuue,
Minako
Sumi, Mitsuhiko
National
Cancer
Center
Puroose/Obie&
has been
esophagectomy
with 3 fields
of some reasons, radiotherapy
patients
PATIENTS Yuji Tachimori,
Hoichi
Kato.
Hiroshi
Watanabe,
Kouichi
Imai and Shuji Nakayama
SEC
esophageal
treatment
cancer(SEC)
has steadily
of SEC is endoscopical
for submucosal
cancer.
by radiotherapy
Radiotherapy
alternative
increased
mucosal is little
to surgery.
in Japan
resection place
Purpose
as result
(EMR)
of endoscopic
for mucosal
for the management
of this report
cancer
of SEC.
is to evaluate
or
Because
efficacy
of
Reasons
of
for SEC.
Methods
& Materials:
radiotherapy
Between
that waschosen
and double
primary
endoscopy
and radiography.
and I6 patients carcinoma.
cancer
(88.9%)
1989
to 1996,
as the primary in I3 patients
(head
had tumor
invaded
There were 17 male patients
patients
was TINOMO
did both Ex and intracavitary
follow-up
according
was 6 months
Results:
The overall
esophageal
cancer.
and/or
Three
distant
conservative
treatment
Conclusions:
Local
organs.
and neck:
11. simultaneously: with endoscopic
staging
radiotherapy
than esophageal (16.7%)
SEC were
treated
of surgery
with
11). No patients ultrasound.
of these tumors
radiotherapy
in one patient, had indication
Two patients (38.9%)
at our hospital.
poor medical
underwent
external
condition
of EMR.
were multicentric.
All
radiotherapy
(Ex)
Gy of Ex with 5-15 Gy of IC). No patients
received
in 4 patients
Diagnosis
(I I. 1%) had tumor
limited
patients
The age range was 49 years to 87 years with a median
system. Ten patients
with a median
In 2 patients
Seven
patient.
(IC) (30-60
was made by to the mucosa
had squamous
of 62 years.
(50 Gy
cell
Stage of all
66 Gy) alone
chemotherapy.
and 8
Duration
of
of 30 months.
rate was 55.9 % in 3-year patients
with
were rufusal
were examined the submucosa.
to UICC
tumor other
patients
of treatment
and one female
to 96 months
survival
were malignant
eighteen
methods
Some patients
patients
nodes
resection
with
RISK
Yamaguchi.
Japan)
In Japan,
nodes
OF POOR
Hajime
Atsushi
of superficial
common.
lymph
we treated
(Tokyo,
incidence
become
CANCER
Murayama,
Kawashima.
Hospital
The reported
examination
death
ESOPHAGEAL
Ikeda, Shigeyuki
and 14 % in Syear,
cancer
recurred
disease
( 1 I. 1%). esophageal
in 4 patients, in esophagus ulcer
and the cause-specific
intercurrent within
had developed
disease
5year
other
or out of radiation but cured
survival
than malignant fields.
rate was 100 %. Causes tumor
No recurrences
in 3 patients occurred
of
and no in lymph
by
with medication. control
be an alternative
to surgery
with or without
chemotherapy),
and cause-specific in patients
survival
rates were excellent
with SEC. We should
treatment
field,
optimal
do further
administrated
in patients
researches
who had undergone
concerning
dose and so on.
treatment
radiotherapy. method
(Ex alone
to
Adequate to 2.5 or
Radiotherapy
would
or Ex with IC, and